Tekturna Tablet, Film Coated
Product Images NDC 70839-150

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tekturna (NDC 70839-150). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lxo Us Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Tek00 0010 01)

Chemical structure diagram of aliskiren hemifumarate, the active ingredient in Tekturna, depicted with atoms and bonds representing its molecular configuration.*

FDA Label Image

Figure 1 (Tek00 0010 02)

A chart illustrating the impact of co-administered drugs on the pharmacokinetics of aliskiren. It displays fold changes and 90% confidence intervals in Cmax and AUC for various interacting drugs including CYP3A4/P-gp inhibitors, antihypertensives, and other drugs, with corresponding recommendations for dose adjustment or avoidance.*

FDA Label Image

Figure 2 (Tek00 0010 03)

A pharmacokinetic chart showing the fold change and 90% confidence intervals for the area under the curve (AUC) and maximum concentration (Cmax) of aliskiren when co-administered with various drugs including antihypertensives (e.g., hydrochlorthiazide, ramipril, amlodipine), others (e.g., digoxin, metformin, atorvastatin), and warfarin. The chart indicates 'No dose adjustment' recommendations for all listed drugs, comparing fold changes relative to aliskiren alone.*

FDA Label Image

300 mg Label (Tek00 0010 09)

Packaging label for Tekturna (aliskiren) Tablets 300 mg film-coated tablets. The label shows a quantity of 30 tablets with the barcode and NDC 70839-300-30. It is labeled for prescription use only and manufactured by LXO US Inc.*

FDA Label Image

150 mg Label (Tek00 0010 08)

The image shows a blister pack label for Tekturna (aliskiren) tablets, film-coated, with a strength of 150 mg. The package contains 30 tablets and is labeled Rx only. The label includes the NDC 70839-150-30, the LXO logo, and states the drug is manufactured by LXO US Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.